SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-20-003473
Filing Date
2020-10-16
Accepted
2020-10-16 16:57:05
Documents
2
Period of Report
2020-10-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pharmacyte_8k.htm 8-K 18997
2 AMENDMENT NO. 3 TO EXECUTIVE COMPENSATION AGREEMENT pharmacyte_ex1001.htm EX-10.1 13068
  Complete submission text file 0001683168-20-003473.txt   33508
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

IRS No.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 333-68008 | Film No.: 201244508
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences